A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma
Open Access
- 15 June 1991
- Vol. 67 (12) , 2980-2983
- https://doi.org/10.1002/1097-0142(19910615)67:12<2980::aid-cncr2820671207>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- IfosamideJNCI Journal of the National Cancer Institute, 1988
- Iproplatin and carboplatin induced toxicities: Overview of phase II clinical trial conducted by the EORTC early clinical trials cooperative group (ECTG)European Journal of Cancer and Clinical Oncology, 1988
- The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- New drugs in small-cell lung cancerCancer Treatment Reviews, 1986
- Small cell lung cancer 1973–1983: Early progress and recent obstaclesInternational Journal of Radiation Oncology*Biology*Physics, 1984